AD patients had gut dysbiosis, dysregulated SCFA production, and increased IgE levels. Butyrate deficiency and downregulation of GPR109A and PPAR‐γ genes were observed in a mouse model of AD. This evidence concerns the gene HCAR2 and Alzheimer disease.